ATNM

Actinium Pharmaceuticals
$0.85
−$0.01 (−0.7%)Jul 27, 2026
2.0FairMoatMint rating

MoatMint rates Actinium Pharmaceuticals (ATNM) 2.0 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.7 out of 10.

Key metrics

The numbers that frame ATNM today
Market cap
$26.79M
P/E (TTM)
-1.1
EV / FCF
0.6
Gross margin
100%
EV / Sales
-153.5
ROIC
789.7%
Div yield
0%
Debt / equity
0.7
52wk Low
$0.81
52wk High
$1.86

ATNM stock rating

How ATNM scores on quality, value, growth, momentum and financial health
2.0out of 10
Fair overallNeutral business, valuation unclearTop 80% of ~5,000 US stocks
QualityFair2.7/10
GrowthNeutral5.9/10
MomentumPoor1.9/10
ValueNo scoren/a/10
Financial HealthFair2.0/10

Growth

Revenue and earnings trend for ATNM
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ATNM
Is Actinium Pharmaceuticals a good buy?
No. Actinium Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive.
What is the market capitalization of ATNM?
Actinium Pharmaceuticals's market capitalization is $26.79M.
What is the P/E ratio for ATNM stock?
Actinium Pharmaceuticals's current P/E ratio is -1.1.
What is the 52-week high for ATNM stock?
The 52-week high for Actinium Pharmaceuticals is $1.86. The current close of $0.85 is 54.1% below that high.
What is the 52-week low for ATNM stock?
The 52-week low for Actinium Pharmaceuticals is $0.81. The current close of $0.85 is 5.8% above that low.
Does ATNM stock pay dividends?
Actinium Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ATNM?
Actinium Pharmaceuticals's Debt / Equity ratio is 0.66.